Spectral Medical Inc

TSX:EDTCanadaView on OTC Pink - Current Information

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

Contact Information

Headquarters

135 The West Mall, Unit 2TORONTO, ON, Canada M9C 1C2

Phone

416-626-3233

Fax

416-626-3233

Executives

Chairman of the Board, President

Paul Walker

Chief Executive Officer, Chief Financial Officer, Director

Chris Seto

Chief Medical Officer

John Kellum

Director

Cristiano Franzi

Independent Director

Janelle D'Alvise